Company intelligence / Profile preview

Wilmington PharmaTech

Newark, Delaware, United Stateswilmingtonpharmatech.com ↗

Ownership: Private
Employees: ~42
Development stage: Other

Overview

Wilmington PharmaTech is a global contract research and manufacturing organization specializing in chemical process development, medicinal chemistry, custom synthesis, analytical method development/validation, solid-state chemistry (polymorph/salt screening), cGMP API production for clinical trials, genotoxic impurity analysis, stable isotope labeling, chiral resolution/asymmetric catalysis. The company supports pharmaceutical and biotech clients from discovery through clinical phase drug development with state-of-the-art facilities in the US and China.

Modalities: Small molecule
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Wilmington PharmaTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wilmington PharmaTech.

Explore the full profile